Biosynthesis, cleavage, and degradation of the human immunodeficiency virus 1 envelope glycoprotein gp160.
about
Comparative cellular processing of the human immunodeficiency virus (HIV-1) envelope glycoprotein gp160 by the mammalian subtilisin/kexin-like convertasesIsolation of the human PC6 gene encoding the putative host protease for HIV-1 gp160 processing in CD4+ T lymphocytesHuman immunodeficiency virus type 1 glycoprotein precursor retains a CD4-p56lck complex in the endoplasmic reticulumEffects of inefficient cleavage of the signal sequence of HIV-1 gp 120 on its association with calnexin, folding, and intracellular transportFunctional role of the glycan cluster of the human immunodeficiency virus type 1 transmembrane glycoprotein (gp41) ectodomainDifferential activities of the human immunodeficiency virus type 1-encoded Vpu protein are regulated by phosphorylation and occur in different cellular compartmentsSulfation of the human immunodeficiency virus envelope glycoproteinRole of the basic domain of human immunodeficiency virus type 1 matrix in macrophage infectionA conserved dileucine motif mediates clathrin and AP-2-dependent endocytosis of the HIV-1 envelope proteinEfficient trapping of HIV-1 envelope protein by hetero-oligomerization with an N-helix chimera.Recent strategies targeting HIV glycans in vaccine designNovel approaches to inhibit HIV entryReal-time visualization of HIV-1 GAG trafficking in infected macrophagesProteolytic activation of tick-borne encephalitis virus by furinSingle amino acid changes in the human immunodeficiency virus type 1 matrix protein block virus particle productionFormation and intracellular localization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia and Sindbis virusesStructural basis for viral late-domain binding to AlixCrystallographic and Functional Analysis of the ESCRT-I /HIV-1 Gag PTAP InteractionBioinformatic analysis of HIV-1 entry and pathogenesis.Arms Race between Enveloped Viruses and the Host ERAD MachineryOccurrence of an HIV-1 gp160 endoproteolytic activity in low-density vesicles and evidence for a distinct density distribution from endogenously expressed furin and PC7/LPC convertasesEndoprotease activities other than furin and PACE4 with a role in processing of HIV-I gp160 glycoproteins in CHO-K1 cellsThe enhanced immune response to the HIV gp160/LAMP chimeric gene product targeted to the lysosome membrane protein trafficking pathwayThe HIV-1 envelope transmembrane domain binds TLR2 through a distinct dimerization motif and inhibits TLR2-mediated responsesAn efficiently cleaved HIV-1 clade C Env selectively binds to neutralizing antibodiesMutations in the leucine zipper of the human immunodeficiency virus type 1 transmembrane glycoprotein affect fusion and infectivityEffects of amino acid changes in the extracellular domain of the human immunodeficiency virus type 1 gp41 envelope glycoproteinSelection and characterization of human immunodeficiency virus type 1 mutants that are resistant to inhibition by the transdominant negative RevM10 proteinHuman immunodeficiency virus type 1 Nef associates with lipid rafts to downmodulate cell surface CD4 and class I major histocompatibility complex expression and to increase viral infectivity.Stoichiometry of envelope glycoprotein trimers in the entry of human immunodeficiency virus type 1Processing, stability, and receptor binding properties of oligomeric envelope glycoprotein from a primary HIV-1 isolate.Characterization of the biosynthesis of human immunodeficiency virus type 1 Env from infected T-cells and the effects of glucose trimming of Env on virion infectivity.The cytoplasmic domain of human immunodeficiency virus type 1 transmembrane protein gp41 harbors lipid raft association determinantsBinding of human immunodeficiency virus type 1 Gag to membrane: role of the matrix amino terminus.A V3 loop-dependent gp120 element disrupted by CD4 binding stabilizes the human immunodeficiency virus envelope glycoprotein trimer.Stoichiometry of antibody neutralization of human immunodeficiency virus type 1.Functional chimeras of human immunodeficiency virus type 1 Gp120 and influenza A virus (H3) hemagglutininAmino acid 36 in the human immunodeficiency virus type 1 gp41 ectodomain controls fusogenic activity: implications for the molecular mechanism of viral escape from a fusion inhibitorConstruction and characterization of a temperature-sensitive human immunodeficiency virus type 1 reverse transcriptase mutantRole of matrix in an early postentry step in the human immunodeficiency virus type 1 life cycle.
P2860
Q24534205-768861E2-4644-4587-83F0-9211022805D6Q24621842-C6AF5BD7-C7E6-4E91-8A61-A3F288F0A9E3Q24630789-53B24B9A-BCB6-4F5F-945D-E5636FDA990FQ24633832-FD293211-4F4E-454C-8EEF-88A36BDE258CQ24645233-15A48B76-E4BA-4037-A57E-124FCBD827A2Q24646897-4D0A0EE4-B110-44E4-8431-F1AE78BAB9BBQ24647955-21A4BC53-5BD1-437F-AD12-539EF481AE01Q24673913-E5B1CA4A-DB01-403A-AE91-0AA544F02B54Q24681865-CDA194E6-6057-4CB5-89AE-D55E0C365C1FQ24811678-D62D562A-5AED-42D5-AC52-A47F0AA3D4E7Q26823603-51738837-5448-4F61-A119-467A7AF3639EQ27013957-F27883A5-2CD3-4911-83BE-E65CD3B6B9CFQ27318996-29A60929-BCA1-42B1-AB2A-09752A177D1EQ27480892-4DCFFD50-0A5D-491B-AA2B-49F02BC7C9E0Q27485930-787C0D32-2049-433B-BEB0-0D22188E91D8Q27485996-BA69E4A9-42AD-4D1E-843F-0C525C4ABF42Q27643742-1BF113A2-7FBC-419A-A980-4A5E78C409F7Q27665841-0A63C0AB-61C1-40EF-8C08-5CB3CD9B8550Q27693321-3CC8F31E-A47A-4C82-8283-3EAB6A46FF0EQ28078319-9DE43E31-DBFD-4224-84E1-F54044726B45Q28142392-58D1C131-E476-45CA-9550-A60C73560948Q28301298-8E2CDE36-7327-47F8-AC4C-64C8C72191CBQ28306549-89FC2215-B8AF-4E4B-9702-78574CE665B7Q28541978-7BCDE9F0-6223-4580-A7EB-C20EE214E8FFQ28545185-F33A0F31-4719-4643-8883-1BD0C8A91C31Q28646740-62C67945-F5E6-456E-A965-B271C3D6F188Q28646850-0A40DED6-035F-46B8-9DBB-F3EA7DE80439Q30304057-23A6BEEE-C5AF-457D-BA16-965F5FF62347Q30312050-C94ABBE7-4307-40FE-B664-780EBE0E878EQ30447936-73E40D16-2C7D-4F2D-97F9-1E8F921CD36BQ30894431-9722708F-D35A-4B26-95BE-E5E00C6C9099Q31510236-4DAD26F5-E1D3-4003-921D-9C33E88F49C2Q33558652-5E898609-F3EB-4D37-9AF4-13E97C94A6DDQ33647588-DCA17E02-C33B-4F65-82B6-231C0C59BA31Q33725702-74EB09F7-B4EA-41B1-BCDB-85D7A3326031Q33737656-705EBC75-BFC9-4223-BCE9-5C33E81C5DFBQ33780529-3CD98618-7C6B-4190-B2E9-51DF723D0FCAQ33780643-A6204515-C0BA-4FC1-A4EC-CC96C74D2541Q33782366-927760AA-9FFA-41E2-A044-128521C0E635Q33782781-75A227F6-D3D1-4B37-9E6D-09D88BBFBD6B
P2860
Biosynthesis, cleavage, and degradation of the human immunodeficiency virus 1 envelope glycoprotein gp160.
description
1988 nî lūn-bûn
@nan
1988 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1988 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
name
Biosynthesis, cleavage, and de ...... 1 envelope glycoprotein gp160.
@ast
Biosynthesis, cleavage, and de ...... 1 envelope glycoprotein gp160.
@en
type
label
Biosynthesis, cleavage, and de ...... 1 envelope glycoprotein gp160.
@ast
Biosynthesis, cleavage, and de ...... 1 envelope glycoprotein gp160.
@en
prefLabel
Biosynthesis, cleavage, and de ...... 1 envelope glycoprotein gp160.
@ast
Biosynthesis, cleavage, and de ...... 1 envelope glycoprotein gp160.
@en
P2093
P2860
P356
P1476
Biosynthesis, cleavage, and de ...... 1 envelope glycoprotein gp160.
@en
P2093
Bonifacino JS
Klausner RD
P2860
P304
P356
10.1073/PNAS.85.24.9580
P407
P577
1988-12-01T00:00:00Z